Fatigue News and Research

RSS

WVU researchers investigate the best 'dose' of telehealth for patients with chronic conditions

More than ever, patients are using telehealth to ask doctors and nurses about worrying blood-pressure readings, nauseating migraines and stubborn foot ulcers. But for patients with chronic conditions, how frequent should telehealth appointments be? Can that frequency change? Under what conditions?

7 May 2021

Supervised rehabilitation program can help patients with lasting symptoms of COVID-19

Patients with lasting symptoms of COVID-19 who completed a six week, supervised rehabilitation programme demonstrated significant improvements in exercise capacity, respiratory symptoms, fatigue and cognition, according to researchers at the National Institute for Health Research Leicester Biomedical Research Centre - a partnership between Leicester's Hospitals, the University of Leicester and Loughborough University.

7 May 2021

Cancer patients experiencing a deep sense of loneliness and depression during the pandemic

Loneliness and social isolation have been significant problems for the general population during the COVID-19 pandemic, but for cancer patients these issues were particularly acute, likely due to isolation and social distancing, according to a new UCSF study.

6 May 2021

Study reveals sex differences in evaluation and treatment of young adults with chest pain

Among younger adults visiting the emergency department for chest pain, women may be getting the short end of the stick.

6 May 2021

ICU survivors have increased risk of suicide and self-harm, study finds

Admission to an intensive care unit (ICU) is associated with a small increased risk of future suicide or self-harm after discharge compared with non-ICU hospital admissions, finds a study published in The BMJ today.

6 May 2021

Study finds no evidence of increased risk for COVID-19 from aspirin/NSAID use

At the beginning of the pandemic, there were concerns over the use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs), increasing the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. NSAIDs are commonly used to treat SARS-CoV-2 infection-related symptoms such as flu and cough and are frequently taken by older adults with multiple health conditions.

6 May 2021

Many cancer patients are experiencing loneliness and social isolation during COVID-19 pandemic

Loneliness and social isolation, which can have negative effects on health and longevity, are being exacerbated by the COVID-19 pandemic. More than half of surveyed adults with cancer have been experiencing loneliness in recent months, according to a study published early online in CANCER, a peer-reviewed journal of the American Cancer Society.

6 May 2021

Brain imaging study reveals patterns in individuals with sensory processing sensitivity

You know that raw overwhelm people have been reporting after months of a pandemic, compounded by economic issues and social unrest? Does fatigue and compulsive social media scrolling strike a familiar chord?

5 May 2021

UTA researchers investigate a new approach to better treat battlefield TBIs

The chair of the Bioengineering Department at The University of Texas at Arlington is investigating whether a combination of nanoparticles and light therapy can better treat traumatic brain injuries on the battlefield.

4 May 2021

Occupational exposure to low levels of blast linked with neurotrauma biomarker levels

Scientists at the Walter Reed Army Institute for Research demonstrated that biomarkers associated with traumatic brain injury were elevated among law enforcement and military personnel, particularly in active duty participants with longer duration of service.

4 May 2021

Evidence that elevated blood glucose is a significant risk factor for severe COVID-19

The literature analysis pointed to elevated blood glucose levels as a leading facilitator in the progression of COVID-19. Evidence linking elevated glucose to various steps in the life cycle of the virus and presentation of COVID-19 symptoms were also found.

3 May 2021

Tiny 3D brain models could accelerate drug research for multiple sclerosis

Tiny 3-D models that mimic vital aspects of the human nervous system have been developed in a step that could accelerate drug research for neurological conditions such as multiple sclerosis (MS).

3 May 2021

Social cognition may exert a central role in the daily lives of MS patients

An international team of multiple sclerosis (MS) researchers showed that longitudinal changes in social cognition are associated with psychological outcomes of daily living, suggesting that social cognition may exert a central role in people with MS.

3 May 2021

Glandular fever associated with greater risk of depression

New research shows that patients who have had contact with the hospital due to serious glandular disease have a greater risk of subsequently developing depression.

3 May 2021

Most long COVID-19 sequelae affect people under 65, finds study

A new study, released as a preprint on the medRxiv* server, discusses the typical symptoms and signs of this syndrome, with the intention of improving the specificity of detection and reporting.

3 May 2021

A new SARS-CoV-2 variant (HMN.19B) has been identified in France

New research published in the Centers for Disease Control and Prevention’s journal Emerging Infectious Diseases has confirmed the emergence of a new SARS-CoV-2 variant called HMN.19B from the viral clade 19B in France. The 19B viral clade — which includes the D614G variant — was prevalent in late 2019 but had since been rarely observed since early 2020 because of newer viral clades.

3 May 2021

Study finds one-third of COVID-19 patients experience neurological symptoms

The research on the short and long-term effects of COVID-19 disease is ongoing. Still, scientists have found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the brain causing loss of smell and taste, dizziness, muscle pain, fatigue, and other cognitive impairments. However, it remained unknown why certain people developed neurological symptoms while others did not.

3 May 2021

Fatigue News and Research

WVU researchers investigate the best 'dose' of telehealth for patients with chronic conditions

Supervised rehabilitation program can help patients with lasting symptoms of COVID-19

Cancer patients experiencing a deep sense of loneliness and depression during the pandemic

Study reveals sex differences in evaluation and treatment of young adults with chest pain

ICU survivors have increased risk of suicide and self-harm, study finds

Study finds no evidence of increased risk for COVID-19 from aspirin/NSAID use

Many cancer patients are experiencing loneliness and social isolation during COVID-19 pandemic

Brain imaging study reveals patterns in individuals with sensory processing sensitivity

UTA researchers investigate a new approach to better treat battlefield TBIs

Occupational exposure to low levels of blast linked with neurotrauma biomarker levels

Evidence that elevated blood glucose is a significant risk factor for severe COVID-19

Tiny 3D brain models could accelerate drug research for multiple sclerosis

Social cognition may exert a central role in the daily lives of MS patients

Glandular fever associated with greater risk of depression

Most long COVID-19 sequelae affect people under 65, finds study

A new SARS-CoV-2 variant (HMN.19B) has been identified in France

Study finds one-third of COVID-19 patients experience neurological symptoms

Guidance on diagnosis and management of cerebral venous sinus thrombosis after a COVID-19 vaccine

Review: One-third of children develop post-concussion mental health issues

Risk factors for long COVID-19 in children

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News